Study on the Groundwater Accumulation of Oke-Ogba Area using Groundmagnetic Survey

A ground magnetic survey of Oke-Ogba area in Akure part of south western Nigeria was carried out with the aim of establishing dominant hydrogeologic factors responsible for groundwater development of the area. A total of four transverses were established for the groundmagnetic survey, and the results were presented as groundmagnetic profiles of varying magnetic intensities. The  basement topography was obtained from the profiles using half-width method. The interpretation of magnetic intensities of the profiles revealed a network of geological features such as faults, joints and fractures. The high magnetic intensity at the central portion of the constructed magnetic contour map indicates shallow basement. This was corroborated with quantitatively  interpreted result which established overburden thickness to the top of the magnetic basement rock as varied between 3.0 and 21.0m. Groundmagnetic study of Oke-Ogba area has revealed the efficacy of magnetic prospecting technique as a fast reconnaissance tool for identifying geological features and estimation of basement depth. The study has established geological features as more prominent hydrogeologic indicator for groundwater development in the area. @ JASEMJ. Appl. Sci. Environ. Manage. December, 2010, Vol. 14 (4) 25 - 3

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality

Background and purpose: Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods: We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020). Results: There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths. Conclusions: During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality.

BACKGROUND AND PURPOSE: Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year. METHODS: We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020). RESULTS: There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths. CONCLUSIONS: During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT

GPS, scaling exponent and past seismicity for seismic hazard assessment in Garhwal–Kumaun, Himalayan region

The world’s most geologically complex Himalayan arc is well known for its tectonic and seismic activities due to the collision of Indian and Eurasian plates. Based on these elements [global positioning system (GPS) deformation measurements, scaling exponent (D) of the tectonic elements and past seismicity] studied here can contribute to better understanding of dynamics and complexities of earthquakes occurrence in any region. In the present paper, the crustal deformation is analyzed with the 3-year campaign and continuous GPS sites data. The velocity vectors of the sites with IGS05 reference frame ranges from 35 to 50 mm/year and give strain-rate measurements up to 130 × 10−9 strain/year. Further, the study region was divided into number of blocks of 1° × 1° that gives different D value based on the presence and distribution of tectonic elements in a particular block. One of the blocks was identified with very high D value of 1.82, where the least seismic activity and extensive convergence due to strain accumulation in comparison with other blocks of higher capacity dimensional value has been observed. Particularly this block lying between latitude 29°N–30°N and longitude 79°E–80°E is considered to be the probable highest seismic hazard zone in the study area. Significance of the combined application of GPS study, scaling exponent and the characteristics of seismicity are stated as helpful methods in the identification of hazardous zone in the Eastern part of the central seismic gap in the Himalaya or in any active areas of the world